STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 90 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 15.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $2,650,000 | -67.9% | 249,259 | -68.6% | 0.00% | -76.9% |
Q3 2019 | $8,267,000 | -41.0% | 794,208 | -13.1% | 0.01% | -38.1% |
Q2 2019 | $14,005,000 | +313.9% | 914,176 | +247.2% | 0.02% | +320.0% |
Q1 2019 | $3,384,000 | +16.7% | 263,322 | -13.7% | 0.01% | 0.0% |
Q4 2018 | $2,899,000 | +17.9% | 305,176 | +106.0% | 0.01% | +66.7% |
Q3 2018 | $2,459,000 | -5.3% | 148,145 | -8.4% | 0.00% | 0.0% |
Q2 2018 | $2,596,000 | +182.5% | 161,735 | +169.3% | 0.00% | +200.0% |
Q1 2018 | $919,000 | -79.7% | 60,056 | -79.3% | 0.00% | -83.3% |
Q4 2017 | $4,524,000 | +1122.7% | 290,005 | +769.8% | 0.01% | +500.0% |
Q3 2017 | $370,000 | -88.3% | 33,340 | -90.3% | 0.00% | -83.3% |
Q2 2017 | $3,151,000 | -13.9% | 342,546 | -20.0% | 0.01% | -14.3% |
Q1 2017 | $3,661,000 | +108.2% | 428,223 | +160.6% | 0.01% | +75.0% |
Q4 2016 | $1,758,000 | +221.4% | 164,302 | +225.1% | 0.00% | +300.0% |
Q3 2016 | $547,000 | -17.2% | 50,541 | -48.3% | 0.00% | -50.0% |
Q2 2016 | $661,000 | -31.9% | 97,683 | -53.1% | 0.00% | 0.0% |
Q1 2016 | $970,000 | -48.6% | 208,110 | -30.4% | 0.00% | -50.0% |
Q4 2015 | $1,887,000 | +12.8% | 299,083 | +57.8% | 0.00% | +33.3% |
Q3 2015 | $1,673,000 | -59.3% | 189,480 | -45.7% | 0.00% | -62.5% |
Q2 2015 | $4,107,000 | -14.9% | 348,980 | +4.7% | 0.01% | -11.1% |
Q1 2015 | $4,824,000 | +73.0% | 333,412 | +104.0% | 0.01% | +50.0% |
Q4 2014 | $2,788,000 | +82.7% | 163,407 | +33.4% | 0.01% | +50.0% |
Q3 2014 | $1,526,000 | -10.2% | 122,502 | +5.8% | 0.00% | -20.0% |
Q2 2014 | $1,699,000 | -3.5% | 115,835 | +33.9% | 0.01% | 0.0% |
Q1 2014 | $1,761,000 | -3.0% | 86,491 | -6.6% | 0.01% | -16.7% |
Q4 2013 | $1,815,000 | +489.3% | 92,624 | +1262.1% | 0.01% | +500.0% |
Q3 2013 | $308,000 | +48.8% | 6,800 | -21.8% | 0.00% | 0.0% |
Q2 2013 | $207,000 | – | 8,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|